Hermitage Capital
VC Fund
Central, Hong Kong
Hermitage Capital is a technology focused PE firm with US$1.2 billion asset under management. With offices in Hong Kong, Shanghai and New York, Hermitage invests across the value chain of global technology sectors, in particular the AI, EV, Cloud, FinTech and Internet sectors. Founded in 2017 by Sean Xiang, an ex-J.P. Morgan investment banker,Hermitage is partnering with world-class entrepreneurs to create value for the investors, portfolio companies and communities. Hermitage’s active portfolio includes Tencent Music, SenseTime, Horizon Robotics, Airwallex, PingCAP, XtalPi, Innovusion, ScaleFlux, WeDoctor, Lufax, Ximalaya, Medlinker, etc.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Hermitage Capital invests in
Stages Hermitage Capital invests in
Countries Hermitage Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 4 (13%)
- Health Care 4 (13%)
- Artificial Intelligence 4 (13%)
- FinTech 3 (10%)
- Finance 3 (10%)
Stage
- Series C 7 (23%)
- Series B 5 (16%)
- Venture - Series Unknown 4 (13%)
- Series D 2 (6%)
- Series E 2 (6%)
Country
- China 13 (42%)
- United States 4 (13%)
- Hong Kong 2 (6%)
- Australia 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Henry Zhang
President & Managing Partner
|
President & Managing Partner | Total investments: 0 | Find email | |
Sean Xiang
Founder & CEO
|
Founder & CEO | Total investments: 0 | Find email | |
Andy Chang
Partner & CSO
|
Partner & CSO | Total investments: 0 | Find email | |
Michael Zhu
Partner
|
Partner | Total investments: 0 | Find email | |
Sandra Wang
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| D-Robotics is a provider of robotic computing solutions. We're committed to delivering paradigm-shifting products that drive efficiency, simplify development and accelerate innovation. | $400M / Series C / Sep 17, 2026 | ||
| D-Robotics is a provider of robotic computing solutions. We're committed to delivering paradigm-shifting products that drive efficiency, simplify development and accelerate innovation. | $150M / Series B / Mar 16, 2026 | ||
| D-Robotics is a provider of robotic computing solutions. We're committed to delivering paradigm-shifting products that drive efficiency, simplify development and accelerate innovation. | $100M / Series A / May 28, 2025 | ||
|
Zhongke Solid Energy
|
Zhongke Solid Energy is a technology company that specializes in the development and production of all-solid-state battery-related products and comprehensive solutions. | $13.9M / Seed / Mar 08, 2024 | |
| Beijing Weilan New Energy Technology Co., Ltd. is a high-tech enterprise focusing on the development and production of next-generation all-solid-state batteries. One of the battery companies with patents and technologies for all solid-state battery cores. With the core concept of “Huijuwei Blue, Leading Solid State”, the company has a leadingdomestic and international leading technology and development team. | $208.8M / Series D / Nov 04, 2022 | ||
| Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system. | $100M / Series E / Oct 10, 2022 | ||
| MetaX is a integrated circuit design company. | $148.8M / Series B / Jul 05, 2022 | ||
| Innovusion is a leading developer of image grade LiDAR sensor systems for the level 4 and 5 of the autonomous vehicle and ADAS markets. Their unique combination of range, resolution, hardware-accelerated sensor fusion, compact size, ease of integration, and cost-effectiveness makes our products the ideal choice for the most demanding applications.We are venture-backed and headquartered in the heart of Silicon Valley. | $118M / Series C / Jan 01, 2022 | ||
| ScaleFlux is a computer hardware company that delivers benefits to IT infrastructure, deployed in the cloud, hybrid-cloud, or on-prem infrastructure environments. It is a well-funded startup that attracts the brightest and the best talent to develop complex computational algorithms, NVM storage control, application, and kernel-level software,data-driven applications, and efficient hardware solutions. The company has a passion for creating and bringing to market innovative technologies for the rapidly growing data-driven application space and thrives in a highly dynamic, fast-paced, results-driven environment. | Series C / Sep 01, 2021 | ||
| XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enablespharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies. | Series C / Jul 01, 2021 | ||
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Hermitage Capital invest in?
Hermitage Capital invests primarily in Medical, Health Care and Artificial Intelligence startups, most often at Series C and Series B stage. Most of the 31 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Hermitage Capital?
Public channels for Hermitage Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Hermitage Capital?
The team at Hermitage Capital includes Henry Zhang (President & Managing Partner), Sean Xiang (Founder & CEO) and Andy Chang (Partner & CSO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
